News & Articles

CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO

A new prognostic tool developed by an international team led by CTI-Bath paves the way for personalized medicine for cancer patients

FoundationOne Liquid CDx analyzes more than 300 cancer-related genes and multiple genomic signatures to inform treatment decisions for all solid tumor cancers

QIAseq SARS-CoV-2 Primer Panel converts viral RNA samples into libraries ready for sequencing, whereas QIAGEN Digital Insights solutions support COVID-19 drug, vaccine and epidemiology research

Syndromic testing will streamline respiratory infection diagnosis as COVID-19 pandemic collides with start of flu season

The AI-Rad Companion Brain MR and Prostate MR measures volumetric changes in brain, and segments prostate for targeted biopsy under MRI and ultrasound fusion imaging respectively

The Somatom scanner is equipped with a forward-looking camera and motorized wheels, allowing a single technologist to navigate the device through hospital hallways

Access Anti-SARS-CoV-2 is an easy-to-use 10-minute test on a portable device that provides highly accurate results on total Ig antibodies

The new assays are designed to enable turnaround times for next-generation sequencing results of less than 24 hours

The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings

Just leave a quick lab product review today for your chance to scoop one of our weekly $100 prizes

Watch this on-demand webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine

The agreement allows First Genetics to bring its F-Genetics NGS system and in vitro diagnostic assays for reproductive health testing to Russian labs

Scientists are harnessing machine learning to make accurate measurements of breast cancer risk from a patient’s blood cells

Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier

The Oncomine Dx target test aims to identify HER2 gene mutations in non-small lung cancer patients

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers

Your guide to choosing and implementing the best automated solutions for the clinical laboratory

To be in with a chance of winning a $500 Amazon Gift Card, simply cast your vote for the product that has made the most difference to your work

CellaVision integration with HORIBA’s HELO automated hematology platform enables unique two-way data flow and rapid results validation